RIL, Sun Pharma drag Sensex marginally lower, Nifty below 24,450
https://economictimes.indiatimes.com/markets/stocks/news/ril-sun-pharma-drag-sensex-marginally-lower-nifty-below-24450/articleshow/120919025.cms
Indian benchmark indices opened flat on Tuesday, with the BSE Sensex down 69 points and the Nifty50 slipping 18 points. Gains in M&M and Bharti Airtel were offset by losses in Reliance Industries and Sun Pharma. Nifty Pharma dropped significantly as U.S. President Donald Trump signed an executive order impacting drug manufacturing.
https://economictimes.indiatimes.com/markets/stocks/news/ril-sun-pharma-drag-sensex-marginally-lower-nifty-below-24450/articleshow/120919025.cms
Indian benchmark indices opened flat on Tuesday, with the BSE Sensex down 69 points and the Nifty50 slipping 18 points. Gains in M&M and Bharti Airtel were offset by losses in Reliance Industries and Sun Pharma. Nifty Pharma dropped significantly as U.S. President Donald Trump signed an executive order impacting drug manufacturing.
Senores Pharma shares in focus after deal to acquire USFDA-approved epilepsy drug from Wockhardt
https://economictimes.indiatimes.com/markets/stocks/news/senores-pharma-shares-in-focus-after-deal-to-acquire-usfda-approved-epilepsy-drug-from-wockhardt/articleshow/120919393.cms
Senores Pharmaceuticals is set to acquire Wockhardt's USFDA-approved ANDA for Topiramate tablets, a medication used for epilepsy and migraine treatment. This acquisition, valued at USD 111.47 million in the US market, will be funded from the proceeds of Senores' December IPO. Despite a strong market debut, the company's shares have since experienced a decline.
https://economictimes.indiatimes.com/markets/stocks/news/senores-pharma-shares-in-focus-after-deal-to-acquire-usfda-approved-epilepsy-drug-from-wockhardt/articleshow/120919393.cms
Senores Pharmaceuticals is set to acquire Wockhardt's USFDA-approved ANDA for Topiramate tablets, a medication used for epilepsy and migraine treatment. This acquisition, valued at USD 111.47 million in the US market, will be funded from the proceeds of Senores' December IPO. Despite a strong market debut, the company's shares have since experienced a decline.
JM Financial maintains Buy on Hexaware Technologies; lowers target price to Rs 860
https://economictimes.indiatimes.com/markets/stocks/recos/jm-financial-maintains-buy-on-hexaware-technologiesnbsplowers-target-to-rs-860brbr/articleshow/120888351.cms
JM Financial maintains a Buy call on Hexaware Technologies, revising the target price to Rs 860 from Rs 880. Despite a seasonally soft quarter, Hexaware reiterated a positive outlook for CY25, driven by deal ramps and consolidation opportunities. The brokerage lowered CY25E CC growth assumption but expects stable margins, prioritizing growth investments.
https://economictimes.indiatimes.com/markets/stocks/recos/jm-financial-maintains-buy-on-hexaware-technologiesnbsplowers-target-to-rs-860brbr/articleshow/120888351.cms
JM Financial maintains a Buy call on Hexaware Technologies, revising the target price to Rs 860 from Rs 880. Despite a seasonally soft quarter, Hexaware reiterated a positive outlook for CY25, driven by deal ramps and consolidation opportunities. The brokerage lowered CY25E CC growth assumption but expects stable margins, prioritizing growth investments.
Stocks to buy today: HPCL, NBCC among top 7 trading ideas for 6 May, 2025
https://economictimes.indiatimes.com/markets/stocks/news/stocks-to-buy-today-hpcl-nbcc-among-top-7-trading-ideas-for-6-may-2025/articleshow/120919521.cms
Indian markets are likely to open higher on Tuesday, tracking strong global cues. Nifty Futures closed up 0.68% at 24,567 on Monday. FPI and DII inflows remained positive. Options data suggests a trading range of 24,000–25,000. Analysts recommend buying stocks like HPCL, Shriram Finance, NBCC, and Aptech for short-term gains, with Nifty support seen at 24,200.
https://economictimes.indiatimes.com/markets/stocks/news/stocks-to-buy-today-hpcl-nbcc-among-top-7-trading-ideas-for-6-may-2025/articleshow/120919521.cms
Indian markets are likely to open higher on Tuesday, tracking strong global cues. Nifty Futures closed up 0.68% at 24,567 on Monday. FPI and DII inflows remained positive. Options data suggests a trading range of 24,000–25,000. Analysts recommend buying stocks like HPCL, Shriram Finance, NBCC, and Aptech for short-term gains, with Nifty support seen at 24,200.
These 4 F&O stocks saw a high increase in futures open interest
https://economictimes.indiatimes.com/markets/stocks/news/these-4-fo-stocks-saw-a-high-increase-in-futures-open-interest/slideshow/120919689.cms
A significant uptick in futures open interest signifies a substantial growth in the number of active, unexpired futures contracts in a specific security
https://economictimes.indiatimes.com/markets/stocks/news/these-4-fo-stocks-saw-a-high-increase-in-futures-open-interest/slideshow/120919689.cms
A significant uptick in futures open interest signifies a substantial growth in the number of active, unexpired futures contracts in a specific security
Share market update: Most active stocks of the day in terms of total traded value
https://economictimes.indiatimes.com/markets/stocks/stock-watch/share-market-update-most-active-stocks-of-the-day-in-terms-of-total-traded-value/articleshow/120919635.cms
The NSE Nifty index was trading 61.41 points down at 24399.75
https://economictimes.indiatimes.com/markets/stocks/stock-watch/share-market-update-most-active-stocks-of-the-day-in-terms-of-total-traded-value/articleshow/120919635.cms
The NSE Nifty index was trading 61.41 points down at 24399.75
Stock market update: Stocks that hit 52-week lows on NSE
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-stocks-that-hit-52-week-lows-on-nse/articleshow/120920606.cms
Jio Financial Services, Adani Ent., Bajaj Finance, Cipla and Adani Ports SEZ were among the top losers on NSE.
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-stocks-that-hit-52-week-lows-on-nse/articleshow/120920606.cms
Jio Financial Services, Adani Ent., Bajaj Finance, Cipla and Adani Ports SEZ were among the top losers on NSE.
Stock market update: FMCG stocks down as market falls
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-fmcg-stocks-down-as-market-falls/articleshow/120920714.cms
The 30-share BSE Sensex was down 221.32 points at 80575.52
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-fmcg-stocks-down-as-market-falls/articleshow/120920714.cms
The 30-share BSE Sensex was down 221.32 points at 80575.52
Stock market update: Mining stocks down as market falls
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-mining-stocks-down-as-market-falls/articleshow/120920848.cms
The 30-share BSE Sensex was down 215.97 points at 80580.87
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-mining-stocks-down-as-market-falls/articleshow/120920848.cms
The 30-share BSE Sensex was down 215.97 points at 80580.87
Pharma shares slip up to 3% as Trump order to boost U.S. drug manufacturing rattles Indian exporters
https://economictimes.indiatimes.com/markets/stocks/news/pharma-shares-slip-up-to-3-as-trump-order-to-boost-u-s-drug-manufacturing-rattles-indian-exporters/articleshow/120920870.cms
Indian pharmaceutical stocks experienced a significant decline. This followed US President Donald Trump's executive order. The order aims to boost domestic drug production in the United States. Concerns arose about potential disruptions for Indian drug exporters. These exporters heavily rely on the US market. The Nifty Pharma index saw a drop. Companies like Lupin, Aurobindo Pharma, and Cipla faced losses.
https://economictimes.indiatimes.com/markets/stocks/news/pharma-shares-slip-up-to-3-as-trump-order-to-boost-u-s-drug-manufacturing-rattles-indian-exporters/articleshow/120920870.cms
Indian pharmaceutical stocks experienced a significant decline. This followed US President Donald Trump's executive order. The order aims to boost domestic drug production in the United States. Concerns arose about potential disruptions for Indian drug exporters. These exporters heavily rely on the US market. The Nifty Pharma index saw a drop. Companies like Lupin, Aurobindo Pharma, and Cipla faced losses.
These 6 stocks showing RSI Trending Up on May 5
https://economictimes.indiatimes.com/markets/stocks/news/these-6-stocks-showing-rsi-trending-up-on-may-5/slideshow/120921117.cms
When the RSI value crosses above 50 from below, it signals that the Relative Strength Index (RSI) is rising, indicating strengthening momentum in the stock's price. This suggests a potential upward trend.
https://economictimes.indiatimes.com/markets/stocks/news/these-6-stocks-showing-rsi-trending-up-on-may-5/slideshow/120921117.cms
When the RSI value crosses above 50 from below, it signals that the Relative Strength Index (RSI) is rising, indicating strengthening momentum in the stock's price. This suggests a potential upward trend.
Stock market update: Sugar stocks down as market falls
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-sugar-stocks-down-as-market-falls/articleshow/120921142.cms
The 30-share BSE Sensex was down 182.9 points at 80613.94
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-sugar-stocks-down-as-market-falls/articleshow/120921142.cms
The 30-share BSE Sensex was down 182.9 points at 80613.94
The Revival of India's Defense Sector: A Multi-Decade Investment Opportunity
https://economictimes.indiatimes.com/markets/stocks/stock-watch/the-revival-of-indias-defense-sector-a-multi-decade-investment-opportunity/articleshow/120921328.cms
Explore the promising landscape of India's defense sector, driven by strategic government initiatives and robust growth potential. Discover key players and their performance metrics as the sector gears up for a transformative era.
https://economictimes.indiatimes.com/markets/stocks/stock-watch/the-revival-of-indias-defense-sector-a-multi-decade-investment-opportunity/articleshow/120921328.cms
Explore the promising landscape of India's defense sector, driven by strategic government initiatives and robust growth potential. Discover key players and their performance metrics as the sector gears up for a transformative era.
Sensex falls! But these stocks are up over 15% on BSE
https://economictimes.indiatimes.com/markets/stocks/stock-watch/sensex-falls-but-these-stocks-are-up-over-15-on-bse/articleshow/120921339.cms
In the Nifty50 index, 18 stocks were trading in the green, while 32 stocks were in the red.
https://economictimes.indiatimes.com/markets/stocks/stock-watch/sensex-falls-but-these-stocks-are-up-over-15-on-bse/articleshow/120921339.cms
In the Nifty50 index, 18 stocks were trading in the green, while 32 stocks were in the red.
Stock market update: Nifty Pharma index falls 0.88% in a weak market
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-nifty-pharma-index-falls-0-88-in-a-weak-market/articleshow/120921443.cms
The Nifty Pharma index was trading 0.88 per cent down at 21585.05.
https://economictimes.indiatimes.com/markets/stocks/stock-watch/stock-market-update-nifty-pharma-index-falls-0-88-in-a-weak-market/articleshow/120921443.cms
The Nifty Pharma index was trading 0.88 per cent down at 21585.05.
CCL Products shares jump 16% after Q4 net profit surges 56% YoY
https://economictimes.indiatimes.com/markets/stocks/news/ccl-products-shares-jump-16-after-q4-net-profit-surges-56-yoy/articleshow/120921410.cms
CCL Products shares soared nearly 16% following a robust January-March quarter. The company's net profit jumped 56.35% to Rs 101.9 crore. Revenue grew 15% to Rs 836 crore, driven by exports and Vietnam facility output. EBITDA rose 38.3% to Rs 163.3 crore. Analysts predict an 11% upside, with a 'Buy' recommendation. The stock surged 23% in one month.
https://economictimes.indiatimes.com/markets/stocks/news/ccl-products-shares-jump-16-after-q4-net-profit-surges-56-yoy/articleshow/120921410.cms
CCL Products shares soared nearly 16% following a robust January-March quarter. The company's net profit jumped 56.35% to Rs 101.9 crore. Revenue grew 15% to Rs 836 crore, driven by exports and Vietnam facility output. EBITDA rose 38.3% to Rs 163.3 crore. Analysts predict an 11% upside, with a 'Buy' recommendation. The stock surged 23% in one month.
Share market update: Most active stocks on D-Street today in terms of volume
https://economictimes.indiatimes.com/markets/stocks/stock-watch/share-market-update-most-active-stocks-on-d-street-today-in-terms-of-volume/articleshow/120921644.cms
The NSE Nifty index was trading 83.71 points down at 24377.45
https://economictimes.indiatimes.com/markets/stocks/stock-watch/share-market-update-most-active-stocks-on-d-street-today-in-terms-of-volume/articleshow/120921644.cms
The NSE Nifty index was trading 83.71 points down at 24377.45
Sensex falls! But these stocks are up over 10% on BSE
https://economictimes.indiatimes.com/markets/stocks/stock-watch/sensex-falls-but-these-stocks-are-up-over-10-on-bse/articleshow/120921759.cms
In the Nifty 50 index, 16 stocks were trading in the green, while 34 stocks were trading in the red.
https://economictimes.indiatimes.com/markets/stocks/stock-watch/sensex-falls-but-these-stocks-are-up-over-10-on-bse/articleshow/120921759.cms
In the Nifty 50 index, 16 stocks were trading in the green, while 34 stocks were trading in the red.
Eternal sees sharpest EPS cut among Nifty50 companies in April
https://economictimes.indiatimes.com/markets/stocks/news/eternal-sees-sharpest-eps-cut-among-nifty50-companies-in-april/articleshow/120922348.cms
April saw EPS downgrades for 70% of Nifty50 firms, led by Zomato with a 15.1% cut. IT, consumer, and auto sectors faced sharp estimate reductions. Despite strong Q4 beat-miss ratios, FY26 forecasts declined due to global headwinds and underperformance in IT, FMCG, and financials.
https://economictimes.indiatimes.com/markets/stocks/news/eternal-sees-sharpest-eps-cut-among-nifty50-companies-in-april/articleshow/120922348.cms
April saw EPS downgrades for 70% of Nifty50 firms, led by Zomato with a 15.1% cut. IT, consumer, and auto sectors faced sharp estimate reductions. Despite strong Q4 beat-miss ratios, FY26 forecasts declined due to global headwinds and underperformance in IT, FMCG, and financials.
Tale of 2 countries: Pakistan stock market down 4% post Pahalgam attack, India’s Sensex gains 1.5%
https://economictimes.indiatimes.com/markets/stocks/news/tale-of-2-countries-pakistan-stock-market-down-4-post-pahalgam-attack-indias-sensex-gains-1-5/articleshow/120922450.cms
Following the Pahalgam attack, Pakistan's KSE-100 index fell nearly 4%. Fears of military escalation rattled investors. India's Sensex rose 1.5%, defying regional risks. Moody's warned of economic strain on Pakistan. India suspended the Indus Waters Treaty. Foreign investors remained confident in India. Tensions between the two countries remain high. The historical context shows Indian markets have weathered such tensions.
https://economictimes.indiatimes.com/markets/stocks/news/tale-of-2-countries-pakistan-stock-market-down-4-post-pahalgam-attack-indias-sensex-gains-1-5/articleshow/120922450.cms
Following the Pahalgam attack, Pakistan's KSE-100 index fell nearly 4%. Fears of military escalation rattled investors. India's Sensex rose 1.5%, defying regional risks. Moody's warned of economic strain on Pakistan. India suspended the Indus Waters Treaty. Foreign investors remained confident in India. Tensions between the two countries remain high. The historical context shows Indian markets have weathered such tensions.